Recent developments in the epidemiology of prostate cancer

European Journal of Cancer Part A

Volumn 33, Issue 3, 1997, Pages 340-347

  Mettlin, C ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

alcohol; diet; genetics; prostate cancer; tobacco; vasectomy; vitamins

Indexed keywords

ALCOHOL; VITAMIN;

ADULT; AGED; CANCER GENETICS; CANCER MORTALITY; DIET; HUMAN; LIFESTYLE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; VASECTOMY;

EID: 0031106079     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)89003-X     Document Type: Article

References (58)

1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer Statistics 1994. Ca Cancer J Clin. 44:1994;7-26.
2. American Cancer Society. Cancer Facts and Figures. 1996;American Cancer Society, Atlanta. 1996.
3. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. 1993;IARC Scientific Publication No. 121, Lyon.
4. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 54:1993;594-606.
5. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK. SEER Cancer Statistics Review 1973-1992. 1996;National Cancer Institute, NIH Pub No. 96-2789, Bethesda, Maryland.
6. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer. 63:1991;963-966.
7. Mettlin C, Murphy GP, Babaian RJ, et al. The results of a five year early prostate cancer detection intervention. Cancer. 77:1996;150-159.
8. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA. 270:1993;948-954.
9. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 273:1995;548-552.
10. Gilliland F, Becker TM, Smith A, Key CR, Samet JM. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening. Cancer Epidemiol Biomarkers Prev. 3:1994;105-111.
11. Mettlin CJ, Murphy GP, Ho R, Menck HR. Longitudinal observations on prostate cancer in the United States from the American College of Surgeons National Cancer Data Base. Cancer, in press.
12. Ross RK, Bernstein L, Lobo RA, et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 339:1992;887-889.
13. Brawley OW, Ford LG, Thompson I, Perlman JA, Kramer BS. 5-α-reductase inhibition and prostate cancer prevention. Cancer Epidemiol Biomarkers Prev. 3:1994;177-182.
14. Giovannucci E, Rim EB, Colditz GA, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst. 85:1993;1571-1579.
15. La Vecchia C, Negri E, D'Avanzi B, Franceschi S, Boyle P. Dairy products and the risk of prostate cancer. Oncology. 48:1991;406-410.
16. Graham S, Haughey B, Marshall J, et al. Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst. 70:1983;687-692.
17. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst. 86:1994;281-286.
18. Rohan TE, Howe GR, Burch JD, Jain M. Dietary factors and risk of prostate cancer: a case control study in Ontario, Canada. Cancer Causes Control. 6:1995;145-154.
19. Kolonel LN, Yoshizawa CN, Hankin JH. Diet and prostate cancer: a case-control study in Hawaii. Am J Epidemiol. 127:1988;999-1012.
20. Mettlin C, Selenskas S, Natarajan N, Huben R. Beta-carotene animal fats and prostate cancer risk: a case-control study. Cancer. 64:1989;605-612.
21. West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case control study with special emphasis on aggressive tumors. Cancer Causes Control. 2:1991;85-94.
22. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low fat diet. J Natl Cancer Inst. 87:1995;1458-1462.
23. Giovannucci E, Asherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett W. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 87:1995;1767-1776.
24. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 330:1994;1029-1035.
25. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Cancer. 70:1992;2861-2869.
26. Corder EH, Guess HA, Hulka BS, et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev. 2:1993;467-472.
27. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control. 6:1995;235-239.
28. Hiatt RA, Armstrong MA, Klatsky AL, Sidney S. Alcohol consumption smoking and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control. 5:1994;66-72.
29. Slattery ML, West DW. Smoking, alcohol, coffee, tea, caffeine and theobromine: risk of prostate cancer in Utah (United States). Cancer Causes Control. 4:1993;559-563.
30. Tavani A, Negri E, Franceschi S, Talamani R, La Vecchia C. Alcohol consumption and risk of prostate cancer. Nutr Cancer. 21:1994;25-31.
31. Hayes RB, Pottern LM, Swanson GM, et al. Tobacco use and prostate cancer in Blacks and Whites in the United States. Cancer Causes Control. 5:1994;221-226.
32. Talamini R, Franceschi S, La Vecchia C, Guanmeri S, Negri E. Smoking habits and prostate cancer: a case-control study in Northern Italy. Prev Med. 22:1993;400-408.
33. Hsing AW, McLaughlin JK, Hrubec Z, Bot WJ, Fraumeni JF Jr. Tobacco use and prostate. Am J Epidemiol. 133:1991;437-441.
34. Lee I, Paffenbarger RS Jr, Hsieh C. Physical activity and risk of prostatic cancer among college alumni. Am J Epidemiol. 135:1992;169-179.
35. Whittemore AS, Kolonel LN, Wu AH, et al. Prostate cancer in relation to diet physical activity, and body size in blacks, whites and Asians in the United States and Canada. J Natl Cancer Inst. 87:1995;652-661.
36. Hsing AW, McLaughlin JK, Zheng W, Gao Y, Blot WJ. Occupation, physical activity, and risk of prostate cancer in Shanghai, Peoples Republic of China. Cancer Causes Control. 5:1994;136-140.
37. LeMarchand L, Kolonel L, Yoshizawa CN. Lifetime occupational physical activity and prostate cancer risk. Am J Epidemiol. 133:1991;103-111.
38. Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE. Vasectomy, cigarette smoking and age at first sexual intercourse as risk factors for prostate cancer in middle-age men. Br J Cancer. 57:1988;326-331.
39. Mettlin C, Natarajan N, Huben R. Vasectomy and prostate cancer risk. Am J Epidemiol. 132:1990;1056-1061.
40. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. Vasectomy and the risk of prostate cancer. Am J Epidemiol. 132:1990;1051-1055.
41. John EM, Whittemore AS, Wu AH, et al. Vasectomy and prostate cancer: results from a multiethnic case-control study. J Natl Cancer Inst. 87:1995;662-669.
42. Rosenberg L, Palmer JR, Zauber AG, et al. The relation of vasectomy to the risk of cancer. Am J Epidemiol. 140:1994;431-438.
43. Hayes RB, Pottern LM, Greenberg R, et al. Vasectomy and prostate cancer in US blacks and whites. Am J Epidemiol. 137:1993;263-269.
44. Giovanucci E, Tosteson TD, Speizer FE, Ascherio A, Vessey MP, Colditz GA. A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA. 269:1993;878-882.
45. Giovanucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. A prospective cohort study of vasectomy and prostate cancer in US men. JAMA. 269:1993;873-877.
46. Hsing AW, Wang RT, Gu F, et al. Vasectomy and prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 3:1994;285-288.
47. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer. 13:1960;739-744.
48. Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR. Genetic epidemiology of prostate cancer in the Utah Morman genealogy. Cancer Surv. 1:1982;47-69.
49. Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol. 146:1991;1305-1307.
50. Hayes RB, Liff JM, Pottern LM, et al. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer. 60:1995;361-364.
51. Whittemore AS, Wu AH, Kolonel LN, et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol. 14:1995;732-740.
52. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 17:1990;337-347.
53. Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. Br Med J. 305:1992;855-857.
54. Anderson DE, Badzioch MD. Familial breast cancer risks: effects of prostate and other cancers. Cancer. 72:1993;114-119.
55. Andrieu N, Clavel F, Auquier A, et al. Association between breast cancer and family malignancies. Eur J Cancer. 27:1991;244-248.
56. Isaacs SD, Kiemeney LALM, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst. 87:1995;991-996.
57. Mettlin C, Natarajan N, Huben R, Raghavan D. Reported family history of cancer in 1271 prostate cancer cases and 1909 controls. Urol Oncol, in press.
58. Carter BS, Bova GS, Beaty TH, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol. 150:1993;797-802.